TABLE 1.
Basic characteristics of 1297 patients with early‐stage EOC treated with FSS or RCS.
Characteristics | FSS (N = 401) (%) | RCS (N = 896) (%) | p |
---|---|---|---|
Age, mean ± SD | 32.4 ± 5.9 | 38.8 ± 4.7 | <0.001 |
Age | |||
<35 years | 249 (62.1) | 157 (17.5) | <0.001 |
35–39 years | 107 (26.7) | 253 (28.3) | |
≥40 years | 45 (11.2) | 486 (45.2) | |
Histology | |||
Serous carcinoma | 42 (10.5) | 81 (9.0) | <0.001 |
Mucinous carcinoma | 167 (41.5) | 198 (22.1) | |
Endometrioid carcinoma | 75 (21.5) | 289 (32.3) | |
Clear cell carcinoma | 70 (17.5) | 259 (28.9) | |
Others a | 36 (9.0) | 69 (7.7) | |
Stage | |||
IA + IB | 212 (52.9) | 365 (40.8) | <0.001 |
IC | 168 (41.9) | 408 (45.5) | |
II | 21 (5.2) | 123 (13.7) | |
Grade | |||
1 + 2 | 184 (45.9) | 396 (44.2) | <0.001 |
3 | 109 (27.2) | 382 (42.6) | |
Unknown | 108 (26.9) | 118 (13.2) | |
Adjuvant chemotherapy | |||
No | 186 (46.4) | 198 (22.1) | <0.001 |
Yes | 215 (53.6) | 698 (77.9) |
Abbreviations: EOC, epithelial ovarian cancer; FSS, fertility‐sparing surgery; N, number of patients; NOS, not otherwise specified; RCS, radical comprehensive staging surgery, SD, standard deviation.
Others included mixed cell adenocarcinoma; adenocarcinoma, NOS; and carcinoma, NOS.